NOTES_NNS TO_TO THE_DT CONSOLIDATED_JJ FINANCIAL_NNP STATEMENTS_NNS CONTINUED_VBD 24_CD ._.
Group_NNP entities_NNS The_DT Company_NN and_CC the_DT Group_NNP has_VBZ investments_NNS in_IN the_DT following_VBG principal_JJ subsidiary_NN undertakings_NNS which_WDT affected_VBD the_DT profits_NNS or_CC net_JJ assets_NNS of_IN the_DT Group_NNP ._.
Country_NN of_IN incorporation_NN Principal_NN activity_NN Holding_VBG %_NN Gyrus_NNP Medical_NNP Limited_NNP Great_NNP Britain_NNP Design_NNP ,_, development_NN ,_, manufacture_NN and_CC 160,447_CD ordinary_JJ marketing_NN of_IN surgical_JJ systems_NNS shares_NNS of_IN 1_CD each_DT 100_CD 894,532_CD A_DT preference_NN shares_NNS of_IN 50p_JJ each_DT 100_CD 39,389_CD B_NNP preference_NN shares_NNS of_IN 2_CD each_DT 100_CD 589,926_CD AA_NNP convertible_JJ shares_NNS of_IN 1_CD each_DT 100_CD 259,100_CD BB_NNP convertible_JJ shares_NNS of_IN 1_CD each_DT 100_CD Gyrus_NNP Medical_NNP Inc_NNP United_NNP States_NNPS of_IN America_NNP Design_NNP ,_, development_NN ,_, manufacture_NN and_CC 100_CD shares_NNS of_IN US$_$ 0.01_CD each_DT 100_CD marketing_NN of_IN surgical_JJ instruments_NNS Gyrus_NNP International_NNP Ltd_NNP Great_NNP Britain_NNP Sales_NNS and_CC marketing_NN of_IN medical_JJ devices_NNS 50,000_CD ordinary_JJ shares_NNS of_IN 10p_JJ each_DT 100_CD Gyrus_NNP ENT_NNP LLC_NNP United_NNP States_NNPS of_IN America_NNP Design_NNP ,_, development_NN and_CC manufacture_NN 100_CD shares_NNS of_IN US$_$ 0.01_CD each_DT 100_CD of_IN medical_JJ devices_NNS Gyrus_NNP Medical_NNP B._NNP V._NNP Holland_NNP Sales_NNS of_IN medical_JJ devices_NNS 350_CD shares_NNS of_IN 45_CD each_DT 100_CD Gyrus_NNP Medical_NNP B._NNP V._NNP B._NNP A._NNP Belgium_NNP Sales_NNS of_IN medical_JJ devices_NNS 186_CD shares_NNS of_IN 100_CD each_DT 100_CD Gyrus_NNP Medical_NNP GmbH_NNP Germany_NNP Sales_NNS of_IN medical_JJ devices_NNS 100_CD shares_NNS of_IN 260_CD each_DT 100_CD Gyrus_NNP North_NNP American_NNP Sales_NNP Inc_NNP United_NNP States_NNPS of_IN America_NNP Sales_NNS and_CC marketing_NN of_IN medical_JJ devices_NNS 1,000_CD shares_NNS of_IN US$_$ 1_CD each_DT 100_CD Gyrus_NNP Australasia_NNP Pty_NNP Ltd_NNP Australia_NNP Sales_NNS and_CC marketing_NN of_IN medical_JJ devices_NNS 100_CD shares_NNS of_IN AUD$_NNP 1_CD each_DT 100_CD Gyrus_NNP ACMI_NNP Australasia_NNP Ltd_NNP New_NNP Zealand_NNP Sales_NNS and_CC marketing_NN of_IN medical_JJ devices_NNS 100_CD shares_NNS of_IN NZD$_NNP 1_CD each_DT 100_CD ACMI_NNP Corporation_NNP United_NNP States_NNPS of_IN America_NNP Design_NNP ,_, development_NN ,_, manufacture_NN and_CC 1,000_CD shares_NNS of_IN US$_$ 0.01_CD each_DT 100_CD marketing_NN of_IN surgical_JJ systems_NNS ACMI_NNP International_NNP Inc_NNP United_NNP States_NNPS of_IN America_NNP Sales_NNS and_CC marketing_NN of_IN medical_JJ devices_NNS 100_CD shares_NNS of_IN US$_$ 0.01_CD each_DT 100_CD ACMI_NNP Canada_NNP Inc_NNP Canada_NNP Sales_NNS and_CC marketing_NN of_IN medical_JJ devices_NNS 100_CD shares_NNS of_IN CAN$_NNP 0.01_CD each_DT 100_CD CByond_NNP Ltd_NNP Israel_NNP Design_NNP and_CC development_NN 100_CD shares_NNS of_IN 1_CD Israeli_NNP of_IN medical_JJ devices_NNS Shekel_NNP each_DT 100_CD ACMI_NNP Japan_NNP K._NNP K._NNP Japan_NNP Sales_NNS and_CC marketing_NN of_IN medical_JJ devices_NNS 200_CD shares_NNS of_IN 50,000_CD each_DT 100_CD WIT_NNP Holdings_NNPS Inc_NNP United_NNP States_NNPS of_IN America_NNP Holding_NNP company_NN 100_CD shares_NNS of_IN 100_CD US$_$ 0.01_CD each_DT Cabot_NNP Technology_NNP Corporation_NNP United_NNP States_NNPS of_IN America_NNP Holding_NNP company_NN for_IN intellectual_JJ 1,000_CD shares_NNS of_IN 100_CD property_NN assets_NNS US$_$ 0.01_CD each_DT ACMI_NNP SA_NNP France_NNP Sales_NNS and_CC marketing_NN 25,000_CD shares_NNS of_IN 100_CD of_IN medical_JJ devices_NNS 1.52_CD each_DT ACMI_NNP GmbH_NNP Germany_NNP Dormant_NNP 1_CD share_NN of_IN 100_CD 25,564.59_CD WIT_NNP IP_NNP Corporation_NNP United_NNP States_NNPS of_IN America_NNP Holding_NNP company_NN for_IN intellectual_JJ 100_CD shares_NNS of_IN 100_CD property_NN assets_NNS US$_$ 0.01_CD C2Cure_NNP Inc_NNP United_NNP States_NNPS of_IN America_NNP Holding_NNP company_NN 1,025,648_CD shares_NNS of_IN 100_CD US$_$ 0.01_CD each_DT Gyrus_NNP Holdings_NNPS Ltd_NNP Great_NNP Britain_NNP Holding_NNP company_NN 1,650,000_CD ordinary_JJ 100_CD shares_NNS of_IN 1_CD each_DT Gyrus_NNP Investments_NNPS Ltd_NNP Great_NNP Britain_NNP Holding_NNP company_NN 1,650,000_CD ordinary_JJ 100_CD shares_NNS of_IN 1_CD each_DT Gyrus_NNP US_NNP Holding_NNP Corporation_NNP United_NNP States_NNPS of_IN America_NNP Holding_NNP company_NN 1,600_CD shares_NNS of_IN 100_CD US$_$ 0.01_CD each_DT Gyrus_NNP Acquisition_NNP Tennesee_NNP Inc_NNP United_NNP States_NNPS of_IN America_NNP Holding_NNP company_NN 100_CD shares_NNS of_IN 100_CD US$_$ 0.01_CD each_DT indirect_JJ investments_NNS of_IN the_DT Company_NN through_IN wholly_RB owned_VBN intermediary_JJ holding_VBG companies_NNS within_IN the_DT Group_NNP ._.
Gyrus_NNP Group_NNP PLC_NNP Annual_JJ Report_NNP and_CC Accounts_NNPS 2005_CD 76_CD
